ScholarIQanswers from OpenAlex & ORCID
James N. Ingle
ResearcherPublications, citations & collaboration network
James N. Ingle is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does James N. Ingle have?
ScholarIQindexed works
James N. Ingle has 731 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does James N. Ingle have?
ScholarIQcitation count
James N. Ingle has 55,419 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of James N. Ingle?
ScholarIQh-index
James N. Ingle has an h-index of 96 in OpenAlex.
What is the i10-index of James N. Ingle?
ScholarIQi10-index
James N. Ingle has an i10-index of 334 in OpenAlex.
What is the ORCID of James N. Ingle?
ScholarIQorcid
The ORCID for James N. Ingle is on the source record.
What is the OpenAlex record for James N. Ingle?
ScholarIQopenalex
The OpenAlex for James N. Ingle is on the source record.
What are the most-cited papers on James N. Ingle?
ScholarIQmost cited works
Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer
Edward H. Romond, Edith A. Perez, John Bryant, Vera J. Suman, Charles E. Geyer, Nancy E. Davidson, Elizabeth Tan-Chiu, Silvana Martino, Soonmyung Paik, Peter A. Kaufman, Sandra M. Swain, Thomas M. Pisansky, Louis Fehrenbacher, Leila A. Kutteh, Victor G. Vogel, Daniel W. Visscher, Greg Yothers, Robert B. Jenkins, Ann Brown, Shaker R. Dakhil, Eleftherios P. Mamounas, Wilma L. Lingle, Pamela Klein, James N. Ingle, Norman Wolmark
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
Aron Goldhirsch, Eric P. Winer, Alan S. Coates, Richard D. Gelber, Martine Piccart, Beat Thürlimann, Hans-Jörg Senn, Kathy S. Albain, Fabrice André, Jonas Bergh, Hervé Bonnefoi, Denisse Bretel-Morales, Harold J. Burstein, Fátima Cardoso, Monica Castiglione‐Gertsch, Alan S. Coates, Marco Colleoni, Alberto Costa, Giuseppe Curigliano, Nancy E. Davidson, Angelo Di Leo, Bent Ejlertsen, John Forbes, Richard D. Gelber, Michael Gnant, Aron Goldhirsch, Pamela J. Goodwin, Paul E. Goss, Jay R. Harris, Daniel F. Hayes, Clifford A. Hudis, James N. Ingle, Jacek Jassem, Zefei Jiang, Per Karlsson, Sibylle Loibl, Monica Morrow, Moïse Namer, C. Kent Osborne, Ann H. Partridge, Frédérique Penault‐Llorca, Charles M. Perou, Martine Piccart, Kathleen I. Pritchard, Emiel J. Rutgers, Felix Sedlmayer, Semiglazov Vf, Zhi‐Ming Shao, Ian Smith, Beat Thürlimann, Masakazu Toi, Andrew Tutt, Michael Untch, Giuseppe Viale, Toru Watanabe, Nicholas Wilcken, Eric P. Winer, William C. Wood
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
Alan S. Coates, Eric P. Winer, Aron Goldhirsch, A. Goldhirsch, R.D. Gelber, M. Gnant, M. Piccart-Gebhart, B. Thürlimann, H.-J. Senn, Fabrice André, José Baselga, Jonas Bergh, Hervé Bonnefoi, Harold Burstein, Fatima Cardoso, Monica Castiglione‐Gertsch, Coates As, Marco Colleoni, Giuseppe Curigliano, Nancy E. Davidson, Angelo Di Leo, Bent Ejlertsen, John Forbes, Galimberti, Richard D. Gelber, Michael Gnant, Aron Goldhirsch, Aron Goldhirsch, Pamela Goodwin, N Harbeck, D. F. Hayes, Jens Huober, Clifford A. Hudis, James N. Ingle, J Jassem, Zefei Jiang, P Karlsson, Monica Morrow, R ORECCHIA, C. Kent Osborne, Ann H. Partridge, Lorena de la Peña, Martine J. Piccart-Gebhart, Kathleen I. Pritchard, E Rutgers, Felix Sedlmayer, Vladimir Semiglazov, Zhi‐Ming Shao, Ian Smith, Beat Thürlimann, Toi M, Gϋnter von Minckwitz, Giuseppe Viale, von Minckwitz G, Toru Watanabe, Timothy Whelan, Eric P. Winer, Binghe Xu
A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer
Paul E. Goss, James N. Ingle, Silvana Martino, Nicholas J. Robert, Hyman B. Muss, Martine Piccart, Monica Castiglione, Dongsheng Tu, Lois E. Shepherd, Kathleen I. Pritchard, Robert B. Livingston, Nancy E. Davidson, Larry Norton, Edith A. Perez, Jeffrey S. Abrams, Patrick Therasse, Michael Palmer, Joseph L. Pater
Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741
Marc L. Citron, Donald A. Berry, Constance Cirrincione, Clifford A. Hudis, Eric P. Winer, William J. Gradishar, Nancy E. Davidson, Silvana Martino, Robert B. Livingston, James N. Ingle, Edith A. Perez, John T. Carpenter, David D. Hurd, James F. Holland, Barbara L. Smith, Carolyn I. Sartor, Eleanor H. Leung, Jeffrey S. Abrams, Richard L. Schilsky, Hyman B. Muss, Larry Norton